Federal contract award

75F40124C00049

CLOUD-BASED TRANSNATIONAL REGULATORY PLATFORM FOR MULTI-REGION REGULATORY COLLABORATION

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541611 — Administrative Management and General Management Consulting Services
PSCB529 — Scientific Data Studies
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$1.9M
Current contract value$1.9M
Potential contract value / ceiling$3.6M
Start dateApr 30, 2024
Current end dateApr 30, 2025
Potential end dateApr 30, 2026
Latest award activityMay 5, 2025
Source loadedAug 15, 2026

Funding and modification history

Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 5, 2025P00002$0CLOUD-BASED TRANSNATIONAL REGULATORY PLATFORM FOR MULTI-REGION REGULATORY COLLABORATION THE PURPOSE OF THIS MODIFICATION IS TO CORRECT THE PERIOD OF PERFORMANCE FROM 4/30/2026 TO THE ONE YEAR BASE PERIOD OF 4/30/2025. ALL OTHER TERMS AND CONDITIONS

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Ian WeissContactIan.Weiss@fda.hhs.gov
3017965728
SourceJan 25, 2024
Ian WeissContactIan.Weiss@fda.hhs.gov
3017965728
SourceJan 16, 2024
Ian WeissContactIan.Weiss@fda.hhs.gov
3017965728
SourceDec 28, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
3017965728
SourceNov 2, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
3017965728
SourceOct 20, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
3017965728
SourceOct 18, 2023
Ian WeissContactIan.Weiss@fda.hhs.gov
3017965728
SourceOct 2, 2023

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.